InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Levitz Michael L, Chief Financial Officer. Insider active across 2 companies, notably Anika Therapeutics, Inc.. In total, 9 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €187k. Activity tracked since 10 August 2021. The latest transaction was disclosed on 11 March 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Levitz Michael L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
4,438 shares0Common StockSEC:0001171843-24-001304:0
3,859 shares0Common StockSEC:0001171843-23-005271:0
8,888 shares0Common StockSEC:0001171843-23-001686:0
4,439 shares0Common StockSEC:0001171843-23-001597:0
3,859 shares0Common StockSEC:0001171843-22-005617:0
4,000 shares@ US$24.61947.8% of flowCommon StockSEC:0001171843-22-001832:0
Canonical exit: 9 Jun 2022 (T+90)
4,438 shares0Common StockSEC:0001171843-22-001812:0
2,850 shares@ US$40.20652.2% of flowCommon StockSEC:0001171843-21-005933:0
Canonical exit: 9 Nov 2021 (T+90)
3,859 shares0Common StockSEC:0001171843-21-005897:0
9 of 9 declarations
About Levitz Michael L
Levitz Michael L is Directeur Financier at Anika Therapeutics, Inc., where he serves as EVP, CFO, Treasurer. He has 9 filings in total, and across the 9 sampled filings the transactions are option exercises, with EUR 186999 of buys, EUR 0 of sells, between 2021-08-12 and 2024-03-12.
